enVVeno Medical Corporation Common Stock NVNO · Stock Open enVVeno Medical Corporation Common Stock in new tab
enVVeno Medical Corporation Common Stock Analysis (NVNO)
Is enVVeno Medical Corporation Common Stock a good investment? enVVeno Medical Corporation Common Stock (NVNO) is currently trading at 10.67 USD.
Earnings Schedule: enVVeno Medical Corporation Common Stock is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is -6.22.
Investor FAQ
Does enVVeno Medical Corporation Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is enVVeno Medical Corporation Common Stock?
enVVeno Medical Corporation Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of -31.20.
Company Profile
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 30, 2020 | 0.040000 |
| Jan. 20, 2026 | 0.030000 |
Community Discussion